Log In
BCIQ
Print this Print this
 

PTI-130

  Manage Alerts
Collapse Summary General Information
Company Proteostasis Therapeutics Inc.
DescriptionCystic fibrosis transmembrane conductance regulator (CFTR) amplifier
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today